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SPHINGOSINE-1-PHOSPHATE DYSREGULATION AND THE
DEVELOPMENT OF PELVIC ORGAN PROLAPSE
Colin Sperling1, BA; Tamara Toidze2, MD; Michael DiSanto3, PhD
Department of Biomedical Sciences, Cooper Medical School of Rowan University 
& Division of Urogynecology, Cooper University Hospital
INTRODUCTION & OBJECTIVES
BACKGROUND
METHODS
• Anterior vaginal wall smooth muscle and epithelial tissue samples were obtained from 
women undergoing surgery at Cooper University Hospital
• Control Samples:  obtained from women undergoing routine hysterectomy with no 
history of POP
• Experimental Samples: obtained from women with POP undergoing reconstructive 
surgical repair
• Tissue samples were extracted into SDS-PAGE sample buffer.  Quantitative Western 
Blot analyses using Bio-Rad’s No-Stain Gel line/Trans-Blot Turbo Blotting 
System/ChemiDoc Imager/Image Lab 6.0 software and fluorescently tagged 
antibodies were used to determine relative expressions of SPHK1, SPHK2, & SPP1. 
• Total Protein Normalization (Fig. A): Relative expression of target protein to total 
lane protein visible on ultraviolet light-activated no-stain was determined which 
minimized the effects of unequal loading between lanes. 
RESULTS
Figure 1: Vaginal Smooth Muscle Tissue 
• SPHK1 expression 46% lower in POP compared to controls normalized to total protein
DISCUSSION & CONCLUSIONS
• Our novel data suggests that SPHK1 is the predominant sphingosine kinase in 
human anterior vaginal SM and epithelial tissue samples and that its levels are 
decreased dramatically in women with POP compared to controls. 
• Levels of SPP1 were also found to be lower in vaginal wall smooth muscle (but 
only slightly).  The larger decrease in SPHK1 vs SPP1 expression would suggest a 
shift toward a higher sphingosine-to-S1P ratio and  thus a shift toward apoptosis 
and cell cycle arrest and overall decreased vaginal wall stability. 
• These findings suggest a POP preventative treatment strategy of stabilizing SPHK1 
levels in the vagina.
• Our study utilized human samples making our findings translationally relevant. 
• A limitation of our data is that only 5 control and 5 POP human samples were 
utilized.  More samples will be analyzed in the future.
• Pelvic Organ Prolapse (POP) is a disorder that occurs when the 
musculature of the pelvic floor weakens, resulting in pathologic 
descent of pelvic organs into the vaginal canal.
• While risk factors for POP have been suggested such as genetic 
predisposition, childbirth, obesity, and advancing age, the etiology 
of this condition remains largely unknown.  
• Females have an 11% lifetime risk of POP which can result in 
urinary, bowel, and sexual dysfunction that can significantly 
impair a woman’s quality of life.1
• Sphingosine-1-Phosphate (S1P) is a bioactive lysosphingolipid
with countless metabolic functions including regulation of cell 
proliferation and smooth muscle (SM) contractility.2 S1P is 
generated by the phosphorylation of sphingosine by sphingosine 
kinase, which exists as two major isoforms (SPHK1 & SPHK2).  
• We hypothesized that SPHK isoform expression could be altered 
in vaginal SM, thereby leading to decreased vaginal wall stability 
and subsequent POP. 
Figure 2: Vaginal Epithelial Tissue
• SPHK1 expression 40% lower in POP compared to controls normalized to total protein
Figure 3: Vaginal Smooth Muscle Cells 
• SPP1 expression 13% lower in POP compared to controls normalized to total protein
Schematic A: Demonstrating the 
biosynthetic pathway of pro-
apoptotic  sphingosine, which is 
implicated in the development 
of POP, and anti-apoptotic S1P, 
which is thought to stabilize 
smooth muscle by promoting 
growth and proliferation. 
Schematic A:
Schematic B:
Schematic B: 3
Representation of the S1P 
pathway.  Binding of S1P 
to its receptors (S1P2, 
S1P3) results in smooth 
muscle contraction.
__________________________________
___________________________________
Figure 4: Human Tissue Extracts. 
12.5 Demonstrates the presence of SPHK1 (Left) and SPP1 (Right) in human vaginal, 
cardiac, and skeletal muscle.  The presence of these enzymes in human bladder 
samples was inconclusive.
Additional Blots not shown:
• Using the same exact SM and epithelial samples under identical conditions, we 
could not identify SPHK2 in either control or POP samples.  
• We could not identify SPP1 in epithelial samples.
1.)  Aponte MM, Rosenblum N. Repair of pelvic organ prolapse: what is the goal? Curr Urol Rep. 2014;15(2):385
2.)  Proia RL, Hla T. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest.                  
2015;125(4):1379-87.
3.) Aydin M, Downing K, Villegas G, Zhang X, Chua R, Melman A, DiSanto ME.  The sphingosine-1-phosphate pathway is 
upregulated in response to partial urethral obstruction in male rats and activates RhoA/Rho-kinase signalling. BJU Int. 
2010;106(4):562-71.
REFERENCES
Figure A: Demonstrating the process of total protein normalization.  
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